BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$126M
This Quarter Return
-38.93%
1 Year Return
+132.45%
3 Year Return
+197.53%
5 Year Return
–
10 Year Return
–
AUM
$211M
AUM Growth
+$211M
(-36%)
Cap. Flow
-$41.3M
Cap. Flow
% of AUM
-19.58%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
16
New
3
Increased
6
Reduced
–
Closed
6
Top Buys
| 1 |
Pacific Biosciences
PACB
|
$24.2M |
| 2 |
Guardant Health
GH
|
$17.9M |
| 3 |
Natera
NTRA
|
$16.5M |
| 4 |
10x Genomics
TXG
|
$16.1M |
| 5 |
CareDx
CDNA
|
$6.64M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$52.2M |
| 2 |
Bio-Techne
TECH
|
$28.3M |
| 3 |
Agilent Technologies
A
|
$26.8M |
| 4 |
Avantor
AVTR
|
$17.3M |
| 5 |
Danaher
DHR
|
$10.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Natera
NTRA
$23.1B
| $45.9M | 21.78% |
1,127,981
+405,800
| +56% | +$16.5M |
|
|
2
Guardant Health
GH
$8.41B
| $43.8M | 20.79% |
661,445
+270,500
| +69% | +$17.9M |
|
|
3
CareDx
CDNA
$727M
| $37.9M | 17.99% |
1,024,515
+179,545
| +21% | +$6.64M |
|
|
4
Pacific Biosciences
PACB
$393M
| $24.2M | 11.49% |
+2,660,000
| New | +$24.2M |
|
|
AKYA
5
DELISTED
Akoya BioSciences
AKYA
| $23M | 10.89% |
2,088,668
+377,861
| +22% | +$4.15M |
|
|
6
10x Genomics
TXG
$1.74B
| $16.1M | 7.65% |
+211,917
| New | +$16.1M |
|
|
SLGC
7
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $7.96M | 3.78% |
992,086
+591,098
| +147% | +$4.74M |
|
8
Ginkgo Bioworks
DNA
$750M
| $7.18M | 3.41% |
1,781,684
+51,893
| +3% | +$209K |
|
|
OLK
9
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $3.72M | 1.76% |
+210,439
| New | +$3.72M |
|
|
PEAR
10
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
| $983K | 0.47% |
194,686
| – | – |
|
|
11
Agilent Technologies
A
$35.7B
| – | – |
-168,150
| Closed | -$26.8M |
|
|
12
Avantor
AVTR
$9.18B
| – | – |
-410,270
| Closed | -$17.3M |
|
|
13
Danaher
DHR
$147B
| – | – |
-31,400
| Closed | -$10.3M |
|
|
14
Bio-Techne
TECH
$8.5B
| – | – |
-54,711
| Closed | -$28.3M |
|
|
15
Thermo Fisher Scientific
TMO
$186B
| – | – |
-78,300
| Closed | -$52.2M |
|
|
BTTX
16
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
| – | – |
-100,000
| Closed | -$465K |
|